MedTrace Logo

Monitoring Neural Tissues Properties by Modulated Imaging (MI)

NCT00555711 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-10-20

No results posted yet for this study

Summary

We have developed a safe, non-contact, intra-operative guidance system to optimize tumor resection in neurosurgery. The Modulated Imaging is non-contact optical imaging technology developed at the Beckman Laser Institute, UCI.

Compared to other imaging approaches, MI has the unique capability of performing both diffuse optical tomography and rapid, wide-field quantitative mapping of tissue optical properties within a single measurement platform.

Preliminary in vivo studies have shown that brain tumors, infiltrating tumor margins and normal brain may have intrinsically different optical properties.

Conditions

Interventions

DEVICE

Modulated Imaging

Modulated Imaging

Sponsors & Collaborators

  • Beckman Laser Institute University of California Irvine

    collaborator OTHER

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Mark Linskey, MD · University of California, Irvine

  • Bruce J Tromberg, PhD · Beckman Laser Institute University of California Irvine

Eligibility

Min Age
1 Minute
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00555711 on ClinicalTrials.gov